WOODCLIFF LAKE, N.J. (AP) _ Eagle Pharmaceuticals Inc. (EGRX) on Tuesday reported second-quarter net income of $2.7 million.
On a per-share basis, the Woodcliff Lake, New Jersey-based company said it had profit of 17 cents. Earnings, adjusted for non-recurring costs and stock option expense, were 95 cents per share.
The specialty pharmaceutical company posted revenue of $59.3 million in the period.
Eagle Pharmaceuticals shares have increased 44 percent since the beginning of the year. The stock has increased 61 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EGRX at https://www.zacks.com/ap/EGRX